Canada markets open in 3 hours 34 minutes

Fusion Antibodies plc (FAB.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
3.3000+0.1000 (+3.12%)
As of 09:09AM BST. Market open.
Currency in GBp

Valuation Measures4

Market Cap (intraday) 3.05M
Enterprise Value 2.61M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.74
Price/Book (mrq)2.10
Enterprise Value/Revenue 1.65
Enterprise Value/EBITDA -7.01

Trading Information

Stock Price History

Beta (5Y Monthly) 0.40
52-Week Change 3-61.21%
S&P500 52-Week Change 324.96%
52 Week High 39.8750
52 Week Low 33.0200
50-Day Moving Average 33.5218
200-Day Moving Average 34.3513

Share Statistics

Avg Vol (3 month) 3966.83k
Avg Vol (10 day) 3639.16k
Shares Outstanding 595.37M
Implied Shares Outstanding 695.37M
Float 855.99M
% Held by Insiders 110.37%
% Held by Institutions 124.43%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin -179.67%
Operating Margin (ttm)-262.29%

Management Effectiveness

Return on Assets (ttm)-62.52%
Return on Equity (ttm)-140.93%

Income Statement

Revenue (ttm)1.58M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)-71.00%
Gross Profit (ttm)N/A
EBITDA -2.8M
Net Income Avi to Common (ttm)-2.84M
Diluted EPS (ttm)-0.0900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)487k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)47k
Total Debt/Equity (mrq)3.23%
Current Ratio (mrq)3.26
Book Value Per Share (mrq)0.02

Cash Flow Statement

Operating Cash Flow (ttm)-2.35M
Levered Free Cash Flow (ttm)-1.15M